Edgewise Therapeutics (EWTX) Other Non-Current Assets (2020 - 2025)
Edgewise Therapeutics (EWTX) reported Other Non-Current Assets of $695000.0 for Q1 2025, up 165.27% sequentially from $262000.0 in Q4 2024.
Edgewise Therapeutics (EWTX) Other Non-Current Assets (2020 - 2025) Analysis & Trends
Edgewise Therapeutics (EWTX) has 6 years of Other Non-Current Assets data on file, last reported at $695000.0 in Q1 2025.
- For the quarter ending Q1 2025, Other Non-Current Assets changed N/A year-over-year to $695000.0; the trailing twelve-month figure through Mar 2025 stood at $695000.0 (changed N/A YoY), and the FY2024 full-year result was $262000.0, down 24.71% from the prior year.
- Other Non-Current Assets rose to $695000.0 in Q1 2025, from $262000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $695000.0 in Q1 2025 to a low of $201000.0 in Q1 2021.
- A 5-year average of $368733.3 and a median of $295000.0 in 2021 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets surged 178.11% in 2022 and tumbled 55.1% in 2023, its largest moves.
- Tracing EWTX's Other Non-Current Assets over 5 years: stood at $548000.0 in 2021, then sank by 54.2% to $251000.0 in 2022, then surged by 38.65% to $348000.0 in 2023, then fell by 24.71% to $262000.0 in 2024, then jumped by 165.27% to $695000.0 in 2025.
- Business Quant data shows EWTX's Other Non-Current Assets at $695000.0 in Q1 2025, $262000.0 in Q4 2024, and $262000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Edgewise Therapeutics | 4.21 Bn | 4.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 695,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Sep 30, 2024 | 262,000.00 |
| Jun 30, 2024 | 262,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Sep 30, 2023 | 467,000.00 |
| Jun 30, 2023 | 419,000.00 |
| Mar 31, 2023 | 251,000.00 |
| Dec 31, 2022 | 251,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 447,000.00 |
| Mar 31, 2022 | 559,000.00 |
| Dec 31, 2021 | 548,000.00 |
| Sep 30, 2021 | 295,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Dec 31, 2020 | 975,000.00 |